Exact Mass: 481.08475660000005

Exact Mass Matches: 481.08475660000005

Found 97 metabolites which its exact mass value is equals to given mass value 481.08475660000005, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Yersiniabactin

C21H27N3O4S3 (481.1163622000001)

A member of the class of thiazolidines that is (4S)-4-methyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid which is substituted at position 2 by a (1S)-1-hydroxy-1-{(4R)-2-[(4R)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl}-2-methylpropan-2-yl group. A siderophore found in the gram-negative bacterium species, Yersinia enterocolitica and Yersinia pestis. D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents

Talampicillin

4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-,1,3-dihydro-3-oxo-1-isobenzofuranyl ester, (2S,5R,6R)-

C24H23N3O6S (481.13074980000005)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D08557

N-(2,2,2-Trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide

N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide

C17H12F9NO3S (481.0394150000001)

T0901317 is an orally active and highly selective LXR agonist with an EC50 of 20 nM for LXRα[1]. T0901317 activates FXR with an EC50 of 5 μM[2]. T0901317 is RORα and RORγ dual inverse agonist with Ki values of 132 nM and 51 nM, respectively[3]. T0901317 induces apoptosis and inhibits the development of atherosclerosis in low-density lipoprotein (LDL) receptor-deficient mice[4][5].

Cycloprothrin

C26H21Cl2NO4 (481.08475660000005)

T0901317

N-(2,2,2-Trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide

C17H12F9NO3S (481.0394150000001)

6-(Methylsulfonyl)hexyl glucosinolate

{[(e)-(7-methanesulphonyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}heptylidene)amino]oxy}sulphonic acid

C14H27NO11S3 (481.0746192)

6-(Methylsulfonyl)hexyl glucosinolate is present in crucifers. Present in crucifers

Talampicillin

2-Amino-N-(3,3-dimethyl-7-oxo-2-{[(3-oxo-1,3-dihydro-2-benzofuran-1-yl)oxy]carbonyl}-4-thia-1-azabicyclo[3.2.0]heptan-6-yl)-2-phenylethanimidate

C24H23N3O6S (481.13074980000005)

Yersiniabactin

2-(1-hydroxy-1-{2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl}-2-methylpropan-2-yl)-4-methyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid

C21H27N3O4S3 (481.1163622000001)

Glucomalcomiin

3-Benzoyloxypropyl glucosinolate

C17H23NO11S2 (481.0712488)

Acquisition and generation of the data is financially supported by the Max-Planck-Society

Glucobenzosisymbrin

2-Benzoyloxy-1-methylethyl glucosinolate

C17H23NO11S2 (481.0712488)

6-Hydroxydelphinidin 3-glucoside

2- (3,4,5-Trihydroxyphenyl) -3- (beta-D-glucopyranosyloxy) -5,6,7-trihydroxy-1-benzopyrylium

C21H21O13 (481.0982116)

Maybridge4_000191

C22H28ClN3O3S2 (481.1260528000001)

Cys Cys Glu Gln

(4S)-4-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}butanoic acid